The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,963,261 in first-year total cost, median $3,342,300.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JBS-A (J1)]2
- Special Emphasis Panel[ZAI1 VV-A (J1)]1
Most frequent institutions
- INTERNATIONAL AIDS VACCINE INITIATIVE1
- TEXAS BIOMEDICAL RESEARCH INSTITUTE1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design1P01AI131251-01 | SHAW, GEORGE M | UNIVERSITY OF PENNSYLVANIA, PA | $3,342,300 | ZAI1 |
| 2016 | Defense-in-depth against mucosal HIV clade C invasion2P01AI048240-12A1 | RUPRECHT, RUTH MARGRIT | TEXAS BIOMEDICAL RESEARCH INSTITUTE, TX | $4,095,518 | ZAI1 |
| 2016 | Pushing the envelope: Optimizing vaccine display of flexibly linked HIV Env trimer immunogens1P01AI124337-01 | PARKS, CHRISTOPHER | INTERNATIONAL AIDS VACCINE INITIATIVE, NY | $2,525,443 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.